GNI Group Ltd.

2160

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-14FY2026 Q2

Revenue

265.2100M JPY

YoY +9.9%

Operating Income

5.3100M JPY

YoY +145.3%

Net Income

-53.2100M JPY

YoY -3510.0%

EPS

-35.7JPY

YoY -96.0%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

268.4億円

190.7億円

113億円

35.3億円

-42.4億円

Rev: 126.9億円Op: 16.2億円NI: 10.7億円

Rev: 174.2億円Op: 13.8億円NI: 3.9億円

Rev: 260.1億円Op: 131.1億円NI: 80.9億円

Rev: 236.1億円Op: 14億円NI: 11億円

Rev: 268.4億円Op: -34.7億円NI: -42.4億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress119.400M

Revenue Forecast473.300M

Net Income Progress-19.900M

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan